Research Peptide Vials
AOD-9604
AOD-9604 is a modified fragment (hGH 176–191) of human growth hormone. It retains the lipolytic region of hGH without affecting IGF-1 levels or causing insulin resistance, making it a selective research tool for studying adipose tissue metabolism.
Product Name: | AOD 9604 |
Synonyms: | AOD 9604;polypeptide AOD 9604;peptides AOD9604;L-Phenylalanine, L-tyrosyl-L-leucyl-L-arginyl-L-isoleucyl-L-valyl-L-glutaminyl-L-cysteinyl-L-arginyl-L-seryl-L-valyl-L-α-glutamylglycyl-L-seryl-L-cysteinylglycyl-, cyclic (7→14)-disulfide;Injectable Lyophillzed Powder Peptides Peptide Aod-9604 Aod9604 Aod 9604 2mg/Vial;HGH frag 176-191 Oxidized;AOD 9604 acetate;Fragment 177-191 |
CAS: | 221231-10-3 |
MF: | C78H123N23O23S2 |
MW: | 1815.1 |
EINECS: | 200-001-8 |
Product Categories: | Research Peptide |
AOD9604 is a peptide fragment (Fragment 177-191) of the C-terminus of Human Growth Hormone to which a tyrosine is added at the N-terminal end. AOD stands for “Anti-Obesity Drug”. This peptide has an amino acid sequence that mimics the lip lytic region of human growth hormone (the region of this hormone thought to be responsible for burning fat) and it has been promoted variously as a weight loss supplement, as an aid to muscle and cartilage repair, and a treatment for osteoarthritis by its manufacturers. Studies have suggested that AOD9604 is more effective than its predecessor AOD9401. Recent clinical research studies have shown that AOD9604 did show a reduction of body fat in the mid abdominal area in both obese, over-weight, and average built people.